HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression ; volume:9 ; number:1 ; day:23 ; month:11 ; year:2010 ; pages:1-10 ; date:12.2010
Molecular cancer ; 9, Heft 1 (23.11.2010), 1-10, 12.2010
- Urheber
-
Baydoun, Hicham H.
Pancewicz, Joanna
Bai, XueTao
Nicot, Christophe
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-9-302
- URN
-
urn:nbn:de:101:1-2021081406030878292899
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Baydoun, Hicham H.
- Pancewicz, Joanna
- Bai, XueTao
- Nicot, Christophe
- SpringerLink (Online service)
Ähnliche Objekte (12)
New insights into HTLV entry
DC-SIGN as a Receptor for HTLV-1 Binding, Entry and Infection
Grundlagen: Signalwege und Checkpoints
Xylosyltransferase 2, a protein encoded on chromosome 17q, is involved in HTLV entry
CD274 promotes cell cycle entry of leukemia-initiating cells through JNK/Cyclin D2 signaling
Cyclin O controls entry into the cell-cycle variant required for multiciliated cell differentiation
The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix
Targeting immune checkpoints in hematological malignancies
Emerging phagocytosis checkpoints in cancer immunotherapy
Comparative virology of HTLV-1 and HTLV-2
Untersuchungen zur Regulation des G1-S-Checkpoints
HTLV-1 epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional proliferative suppression of Tregs
New insights into HTLV entry
DC-SIGN as a Receptor for HTLV-1 Binding, Entry and Infection
Grundlagen: Signalwege und Checkpoints
Xylosyltransferase 2, a protein encoded on chromosome 17q, is involved in HTLV entry
CD274 promotes cell cycle entry of leukemia-initiating cells through JNK/Cyclin D2 signaling
Cyclin O controls entry into the cell-cycle variant required for multiciliated cell differentiation
The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix
Targeting immune checkpoints in hematological malignancies
Emerging phagocytosis checkpoints in cancer immunotherapy
Comparative virology of HTLV-1 and HTLV-2
Untersuchungen zur Regulation des G1-S-Checkpoints
HTLV-1 epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional proliferative suppression of Tregs
New insights into HTLV entry
DC-SIGN as a Receptor for HTLV-1 Binding, Entry and Infection
Grundlagen: Signalwege und Checkpoints
Xylosyltransferase 2, a protein encoded on chromosome 17q, is involved in HTLV entry
CD274 promotes cell cycle entry of leukemia-initiating cells through JNK/Cyclin D2 signaling
Cyclin O controls entry into the cell-cycle variant required for multiciliated cell differentiation
The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix
Targeting immune checkpoints in hematological malignancies
Emerging phagocytosis checkpoints in cancer immunotherapy
Comparative virology of HTLV-1 and HTLV-2
Untersuchungen zur Regulation des G1-S-Checkpoints